Rivaroxaban vs. Apixaban: A Comparative Study on Bleeding Risk and Efficacy in Atrial Fibrillation Treatment
2023-12-17 06:56:00 This was shown by a study presented at the annual meeting of the American Society of Hematology (ASH). Scientists analyzed data from 100 patients collected within a year after anticoagulant prescription. Rivaroxaban resulted in nearly forty bleeding events, and warfarin and apixaban resulted in 25 cases. Warfarin has been associated with more serious … Read more